Stay updated on Subcutaneous Nivolumab + rHuPH20 Clinical Trial

Sign up to get notified when there's something new on the Subcutaneous Nivolumab + rHuPH20 Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Subcutaneous Nivolumab + rHuPH20 Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    This update refreshes the ClinicalTrials.gov page’s revision/version label (v3.5.3), without changing the study’s substantive details.
    Difference
    0.0%
    Check dated 2026-04-27T07:34:05.000Z thumbnail image
  2. Check
    12 days ago
    Change Detected
    Summary
    Revision updated from v3.5.0 to v3.5.2.
    Difference
    0.0%
    Check dated 2026-04-20T02:46:41.000Z thumbnail image
  3. Check
    19 days ago
    No Change Detected
  4. Check
    27 days ago
    Change Detected
    Summary
    Padua, Italy, 35128 was replaced with Padova, Italy, 35128 in the locations list.
    Difference
    0.0%
    Check dated 2026-04-05T16:44:44.000Z thumbnail image
  5. Check
    41 days ago
    Change Detected
    Summary
    Revision: v3.5.0 has been added and Revision: v3.4.3 has been removed. This appears to be a UI/version update with no changes to study data or content.
    Difference
    0.0%
    Check dated 2026-03-22T04:40:44.000Z thumbnail image
  6. Check
    48 days ago
    Change Detected
    Summary
    Revision log updated: added v3.4.3 and removed v3.4.2.
    Difference
    0.0%
    Check dated 2026-03-15T00:29:55.000Z thumbnail image
  7. Check
    78 days ago
    Change Detected
    Summary
    - Revision: v3.4.2 updated; previous v3.4.1 removed; this is a minor administrative update that does not affect study content or user-facing details. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-02-13T12:39:33.000Z thumbnail image

Stay in the know with updates to Subcutaneous Nivolumab + rHuPH20 Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Subcutaneous Nivolumab + rHuPH20 Clinical Trial page.